2008Research Journal of Pharmacy and TechnologyRequires access

Simultaneous RP-HPLC Method for Estimation of Ezetimibe and Simvastatin in Bulk and Dosage Forms

R Siva Kumar, Santhanakrishnan, P. Kumar Nallasivan, R Venkatanarayanan

Open publisher page 5 citations

Abstract

A simple, specific, accurate, precise, rapid and reproducible reverse HPLC method has been developed for the simultaneous estimation of ezetimibe and simvastatin in bulk and tablet dosage forms using C18 column (symmetry, 4.6 mm x 25 cm) in isocratic mode with methanol: water (95:05 v/v) as a mobile phase with the detection wavelength of 248 nm and the flow rate was 0.8 ml/min. The retention time of ezetimibe and simvastatin was found to 3.2 min and be 4.9 min, respectively. Linearity of the ezetimibe and simvastatin was found in the range of 5–70 μg/ml and 5–50 μg/ml, respectively. The recoveries of ezetimibe and simvastatin were found to be in the range of 99.27–101.10% and 99.63100.50%, respectively. The proposed method was validated suitably and can be used for routine analysis.

About this research paper

What this paper is about

A simple, specific, accurate, precise, rapid and reproducible reverse HPLC method has been developed for the simultaneous estimation of ezetimibe and simvastatin in bulk and tablet dosage forms using C18 column (symmetry, 4.6 mm x 25 cm) in isocratic mode with methanol: water (95:05 v/v) as a mobile phase with the detection wavelength of 248 nm and the flow rate was 0.8 ml/min. The retention time of ezetimibe and simvastatin was found to 3.2 min and be 4.9 min, respectively. Linearity of the ezetimibe and simvastatin was found in the range of 5–70 μg/ml and 5–50 μg/ml, respectively. The recoveries of ezetimibe and simvastatin were found to be in the range of 99.27–101.10% and 99.63100.50%, respectively. The proposed method was validated suitably and can be used for routine analysis.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A simple, specific, accurate, precise, rapid and reproducible reverse HPLC method has been developed for the simultaneous estimation of ezetimibe and simvastatin in bulk and tablet dosage forms using C18 column (symmetry, 4.6 mm x 25 cm) in isocratic mode with methanol: water (95:05 v/v) as a mobile phase with the detection wavelength of 248 nm and the flow rate was 0.8 ml/min. The retention time of ezetimibe and simvastatin was found to 3.2 min and be 4.9 min, respectively. Linearity of the ezetimibe and simvastatin was found in the range of 5–70 μg/ml and 5–50 μg/ml, respectively. The recoveries of ezetimibe and simvastatin were found to be in the range of 99.27–101.10% and 99.63100.50%, respectively. The proposed method was validated suitably and can be used for routine analysis.

Key concepts: Ezetimibe, Simvastatin, Chromatography, Dosage form, High-performance liquid chromatography, Methanol, Retention time, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Simultaneous RP-HPLC Method for Estimation of Ezetimibe and Simvastatin in Bulk and Dosage Forms — Research Paper | ScholarLens